Melanotan II is an unlicensed and mostly untested form of alpha-melanocyte-stimulating hormone, which causes pigmentation (tanning) of human skin. Melanotan II is a variant of melanotan I (afamelanotide), a drug used in the treatment of erythropoietic protoporphyria.

Melanotan II is not approved for the treatment of any medical conditions currently. It has been reported to cause a wide range of potentially serious side effects. Warnings against its use have been issued from the US, UK and several additional countries.

Benefits

• Darker tan with less exposure to UV radiation

• Tanning without sunburn, even for fair-skinned individuals

• Possible reduction in the risk of Melanoma (skin cancer)

• Possible reduction in the incidence of sun-damaged skin

• Possible reduction in body fat

• No sunburn or tan lines

• No sunless tanning streaks or fake tan removal

• Possible increase in libido

During clinical trials for its use as a tanning agent, melanotan II was found to be a potent stimulator of male erections. It has also been shown to increase female sexual desire in patients with sexual arousal disorder.

Side Effects

Melanotan-II is POSSIBLY SAFE when used under medical supervision for treating ED (erectile dysfunction). It may cause nausea, stomach cramps, decreased appetite, flushing, tiredness, yawning, darkened skin, spontaneous erections of the penis, and other side effects.